drugset / Trial / NCT05218850

The Use of Butyrate Therapy in Pediatric Ulcerative Colitis

NCT05218850

Phase 2 Recruiting 10 enrolled Children's Hospital Los Angeles
NaSingle-groupOpen-labelTreatment

Summary

Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.

Timeline

Start
2022-06-29
Primary completion
2027-06-30
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject BUTYRIC ACID Small molecule Other

Indications